FDA Adverse Event Injury Summary report: N

ELVIE

MDR report key: 19476768 · Received June 6, 2024

Report

Report Number
3012098706-2024-00040
Event Type
Injury
Date Received
June 6, 2024
Date of Event
May 9, 2024
Report Date
June 6, 2024
Manufacturer
CHIARO TECHNOLOGY
Product Code
KXQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE CUSTOMER HAS CONFIRMED THAT THEY HAVE DEVELOPED A PARASITIC INFECTION AND THAT THEY CAN NOT BE CERTAIN OF THE ORIGIN OF INFECTION. THE CUSTOMER HAS QUESTIONED WHETHER THE DEVICE HAS BEEN REUSED. THE CUSTOMER HAS NOT YET RESPONDED TO CONFIRM WHETHER MEDICAL INTERVENTION AND OR TREATMENT WAS REQUIRED. THE CUSTOMER HAS BEEN ASKED TO PROVIDE FURTHER INFORMATION, SUCH AS THE SERIAL NUMBER AND THE PACKAGING THAT THE DEVICE WAS RECEIVED IN; FOR EXAMPLE, THE PRESCENCE OF SHRINK WRAP. THE CUSTOMER HAS ALSO BEEN ASKED TO CONFIRM WHERE THE DEVICE WAS PURCHASED FROM, TO DETERMINE THAT THE PURCHASED PRODUCT IS FROM AN AUTHORISED SELLER. TO DATE, NONE OF THE ABOVE QUESTIONS HAVE BEEN ANSWERED. CHIARO WILL CONTINUE TO CONTACT THE CUSTOMER FOR FURTHER INFORMATION. IF ANY ADDITIONAL FINDINGS ARE DETERMINED FROM THIS INVESTIGATION, A FOLLOW UP REPORT WILL BE SENT.

Description of Event or Problem · 0

CUSTOMER REPORTED ON (B)(6) 2024 FROM THE US THAT THE ELVIE TRAINER HAD POTENTIALLY CAUSE AN INFECTION. THE CUSTOMER STATED THAT THEY HAD RECEIVED THE PRODUCT AND CLEANED IT, HOWEVER, THEY BEGAN TO DEVELOP SYMPTOMS AND WERE DIAGNOSED WITH A PARASITIC INFECTION. THE CUSTOMER WENT ON TO SAY THAT IT COULD NOT BE DETERMINED WHETHER THE TRAINER WAS THE CAUSE OF THE INFECTION, HOWEVER, THEY WERE CONCERNED THAT THEY MAY HAVE RECEIVED A USED PRODUCT. THE CUSTOMER HAS NOT YET RESPONDED TO CONFIRM WHETHER MEDICAL INTERVEMTION OR TREATMENT WAS REQUIRED, HOWEVER, THIS WILL BE REPORTED OUT OF CAUTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1980306 ELVIE TRAINER KXQ CHIARO TECHNOLOGY EL01

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other